{
    "organizations": [],
    "uuid": "55022e6bb94bd2d3028a2a590c3fca9bc4c30ba7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangzhou-baiyunshan-pharmaceutica/brief-guangzhou-baiyunshan-pharmaceutical-holdings-unit-receives-gmp-certificate-idUSL4N1QN2L3",
    "ord_in_thread": 0,
    "title": "BRIEF-Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd\n* Says coâ€™s unit Guangzhou Baiyunshan Tianxin Pharmaceutical Co Ltd received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration, for powder-injection, small-volume injection, tablet, hard capsule, dry suspension and granule\n* Says the valid period is until Feb. 22, 2023\nSource text in Chinese: goo.gl/Zqxrkh\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-03-05T13:50:00.000+02:00",
    "crawled": "2018-03-06T22:14:57.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "guangzhou",
        "baiyunshan",
        "pharmaceutical",
        "holding",
        "co",
        "ltd",
        "say",
        "co",
        "unit",
        "guangzhou",
        "baiyunshan",
        "tianxin",
        "pharmaceutical",
        "co",
        "ltd",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "guangdong",
        "food",
        "drug",
        "administration",
        "injection",
        "tablet",
        "hard",
        "capsule",
        "dry",
        "suspension",
        "granule",
        "say",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}